-
Curefundr Launches First Crowdfunding Platform Dedicated to Cancer Research
LOS ANGELES, May 11, 2026 /PRNewswire/ — Curefundr has debuted as the first fintech-driven crowdfunding platform built exclusively to bypass the bureaucratic bottlenecks of oncology research. By creating a direct pipeline between global donors and top-tier labs, the platform is designed to eliminate the “funding gap” that frequently stalls breakthrough medical studies before they can reach clinical
-
Landmark CLiMB Study Demonstrates Superior Sensitivity of HelioLiver™, a Multi-Analyte Blood Test, Over Ultrasound for Early Detection of Hepatocellular Carcinoma
Prospective multicenter trial shows HelioLiver™ detects more, early hepatocellular carcinoma than abdominal ultrasound for high-risk patients with cirrhosis IRVINE, Calif., May 6, 2026 /PRNewswire/ — Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced the publication of a study in the Journal of Hepatology demonstrating the performance of HelioLiver™, its multi-analyte noninvasive
-
Prevounce Health Analysis Finds Remote Patient Monitoring Delivers Significant, Sustained Blood Pressure Reductions
INDIANAPOLIS, May 6, 2026 /PRNewswire/ — Prevounce Health, a leading provider of connected care management and remote patient monitoring (RPM) solutions, today released findings from a retrospective cohort analysis of hypertensive patients. The study found that an RPM program, combined with structured virtual care management, produced significant and sustained blood pressure (BP) reductions across a
-
Gallant Advances Canine Osteoarthritis IV-Delivered Stem Cell Therapy with Promising Pilot Data and Expanded FDA Conditional Approval Pathway Eligibility
Recent Milestones Aim to Bring a New Category of Care to One of Veterinary Medicine’s Largest Unmet Needs Gallant granted eligibility for expanded conditional approval by FDA-CVM for canine osteoarthritis (OA) stem cell therapy; targeting conditional approval in 2028. Randomized, blinded, placebo-controlled pilot study shows statistically significant improvement in Gallant’s uterine-derived mesenchymal stromal cell (UMSC)
-
Coral Gables Hospital CEO Natalie Rodriguez Emerges as a Leading Voice in Healthcare and Community Leadership
CORAL GABLES, Fla., May 6, 2026 /PRNewswire/ — Coral Gables Hospital highlights the impactful start of Chief Executive Officer Natalie Rodriguez, whose leadership is already resonating across the City Beautiful through visibility, engagement, and a clear vision for the future. Coral Gables Hospital’s Earth Day Celebration, themed “Growing Today for a Greener Tomorrow.” Fifth Annual
-
Momentum Life Sciences Announces 2026 Impact Award Winners
Annual Recognition Shines the Spotlight on Three Outstanding Team Members During National Nurses Week INDIANAPOLIS, May 6, 2026 /PRNewswire/ — During this year’s National Nurses Week celebration, Momentum Life Sciences presented its annual Impact Awards to three outstanding individuals: Tonja Guthrie, Virtual Nurse Educator, Aimee Johnson, Case Manager and Shari Mott, Field Nurse Educator. Momentum Life
-
Molecular Instruments & Empire Genomics Launch NISH Powered by HCR™ Pro: The Largest Ready-to-Use, Fully Automated ISH Library, Exclusively Available Worldwide on NeoPATH Pro
LOS ANGELES and BUFFALO, N.Y., May 5, 2026 /PRNewswire/ — Empire Genomics, a Biocare Medical company, and Molecular Instruments® (MI), founded by the inventor of HCR™ technology, today launched NISH (Neo in situ hybridization) — the largest ready-to-use, fully automated ISH library for research – exclusively available worldwide on the NeoPATH Pro automated staining platform.
-
RTI International and Navidence Partner to Solve a Persistent Gap in Real-World Evidence: Standardizing How Diseases, Treatments and Outcomes Are Defined
Strategic investment brings together RTI’s scientific leadership and Navidence AI-native platform to improve research quality, reproducibility, and patient outcomes across the life sciences RESEARCH TRIANGLE PARK, N.C., May 5, 2026 /PRNewswire/ — Independent scientific research institute RTI International today announced a partnership and strategic equity investment in Navidence, a technology and knowledge content company focused on defining
-
Free Asbestos Screening Goes Mobile: CARDs Outreach and Education Available Across the Nation
LIBBY, Mont., May 5, 2026 /PRNewswire/ — The Center for Asbestos-Related Disease (CARD), a nationally recognized leader in asbestos-related education, outreach, and research, is expanding its efforts to reach communities across the country while continuing to serve those most affected by exposure. Drawing on decades of experience, CARD works with public health leaders, academic institutions,
-
Lunakai Emphasizes Clean Vitamins Focus Heading Into Summer
The Brand’s Well-Established Approach to Supplementation Continues to Shine in 2026 FORT LAUDERDALE, Fla., May 5, 2026 /PRNewswire/ — Vitamin and supplement trends continue to resemble 2025 heading into the new year. However, there are a few nuances consumers are seeking as they refine their expectations around holistic living. Lunakai is a wellness label that continues
